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InﬂammationThe present study aimed to evaluate the effects of two serine proteases from Bothrops pirajai snake venom,
named BpirSP27 and BpirSP41, on the complement system and the inﬂammatory response. The effects of
these enzymes on the human complement system were assessed by kinetic hemolytic assays, evaluating
the hemolysis promoted by the classical/lectin (CP/LP) and alternative (AP) pathways after incubation of nor-
mal human serum with the serine proteases. The results suggested that these enzymes were able to induce
modulation of CP/LP and AP at different levels: BpirSP41 showed higher inhibitory effects on the hemolytic
activity of CP/LP than BpirSP27, with inhibition values close to 40% and 20%, respectively, for the highest con-
centration assayed. Regarding AP, both enzymes showed percentages of inhibition of the hemolytic activity
around 20% for the highest concentrations tested, indicating similar effects on this complement pathway.
The proinﬂammatory effects of B. pirajai serine proteases were evaluated regarding their ability to induce
paw edema, variations in the pain threshold and leukocyte recruitment at the site of injection. Both showed
mild effects on these inﬂammatory processes, leading to low levels of increase of paw volumes and decrease
in pain thresholds in rats up to 6 h after injection, and inducing neutrophil recruitment without signiﬁcant
increases in the total number of leukocytes in the inﬂammatory exudates after 6 and 24 h of administration
into mice peritoneal cavity. These results suggest that serine proteases must present a minor role in the in-
ﬂammation caused by B. pirajai snake venom.
© 2013 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Envenomation by Bothrops snakes is characterized by severe local
tissue damage, hemorrhage, myonecrosis and prominent inﬂamma-
tion. The inﬂammatory response is an adaptive process in which the
body responds to tissue injury or local infection in order to reestablish
homeostasis, allowing the healing and restoration of damaged sites
[1]. Inﬂammation is initiated and conducted by mediators of plasma
or cellular origin, which promote the typical signs of this response:ical/lectin pathways; LPS, lipo-
sphate buffered saline; SVSPs,
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evier OA license.pain, heat, redness and edema, accompanied or not by loss of function
of the affected tissue or organ [2].
The inﬂammatory response promoted by Bothrops snake venoms
is strictly related to the progress of tissue damage, resulting in
edema and pain, leukocyte inﬁltration and release of cytokines
and other proinﬂammatory mediators [3–5]. Although most of the
available studies indicate a predominant role of phospholipases A2
and metalloproteases in the inﬂammatory effects promoted by
snake venoms [6,7], the role of serine proteases and other compo-
nents of the venom on the inﬂammatory process should not be
discarded [1].
The toxic effects promoted by snake venom serine proteases
(SVSPs) are mainly related to their actions on hemostasis, acting on
several components of the coagulation cascade and the ﬁbrinolytic
and kallikrein–kinin systems, which leads to a hemostatic imbalance
on preys [8,9]. The vast majority of SVSPs are able to promote blood
clotting and resemble, at least partially, thrombin, a multifunctional
protease with essential role in coagulation, thereby being referred
to as snake venom thrombin-like enzymes [10,11].
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coagulation and complement systems, both of which contain series of
serine proteases that form proteolytic cascades, one would expect that
SVSPs could also present signiﬁcant effects on the complement system.
Also, interactions between both systems have often been proposed
[12,13], which could play an important role after snake envenomations
and for subsequent inﬂammatory reactions and complications.
The human complement system is composed of more than 30
plasma and cell surface proteins that participate in many important
biological processes, including the activation of the inﬂammatory pro-
cess in response to the generation of proteolytic fragments of its compo-
nents, and the promotion of phagocytosis and lysis of pathogens and
altered cells by opsonization processes and formation of the membrane
attack complex (MAC). Depending on the stimulus, the activation of the
complement system can occur by three main paths: the classical (CP),
alternative (AP) or lectin (LP) pathways [14]. Some studies also indicate
the existence of additional complement activation paths in the plasma,
which are dependent of different coagulation factors such as thrombin,
FXa, FXIa and plasmin [13,15].
Although several snake venoms present activity on the complement
system [16–18], studies on the action of isolated toxins, especially from
Bothrops venoms, are still scarce. Most snake venom toxins described
with anticomplementary action belong to the class of metalloproteases
[19–21], and in relation to SVSPs, one of the few published studies is
that of Yamamoto and coworkers [22], which showed that ﬂavoxobin
from Trimeresurus ﬂavoviridis snake venom was able to speciﬁcally
cleave human complement protein C3, thus acting as a C3 convertase
enzyme.
Bothrops pirajai serine proteases, called BpirSP27 and BpirSP41,
have recently been characterized by our research group, presenting
signiﬁcant differences in their molecular masses, N-glycosylation
levels and N-terminal sequences, besides different ﬁbrin(ogen)olytic,
coagulant and platelet-aggregating activities [23]. Considering the few
data available in the literature regarding the action of SVSPs on the com-
plement systemand the inﬂammatory response, this study aimed at the
evaluation of the effects of B. pirajai serine proteases on the different
human complement pathways, as well as the proinﬂammatory poten-
tial of these enzymes by the examination of their ability to induce
edema, pain and recruitment of immune cells.
2. Materials and methods
2.1. Materials and toxins
The enzymes BpirSP27 and BpirSP41 were isolated from B. pirajai
snake venom (purchased from the serpentarium Bioagents Bioactive
Proteins Ltd., Batatais-SP, Brazil) by consecutive chromatographic
steps on Sephacryl S-200, Benzamidine Sepharose and C2/C18 columns
(GE Healthcare), as previously described by Menaldo and coworkers
[23]. Other materials and equipment used were described through-
out the methodology and reagents not speciﬁed were of analytical
grade.
2.2. Animals
Male Wistar rats (150–200 g) and female Balb/C mice (20–22 g),
which were used for the evaluation of the proinﬂammatory effects,
were bred and provided by the Animal Facilities of University of São
Paulo, Campus of Ribeirão Preto-SP. Sheep or adult New Zealand
rabbits were held in the Animal Facilities of University of São Paulo,
Campus of Ribeirão Preto-SP, for periodic collection of blood, which
was used in the experiments on the complement system. All experi-
ments involving animals or their blood were approved by the Ethics
Committee on Animal Use of University of São Paulo, Campus of Ribeirão
Preto-SP (CEUA nº. 08.1.192.53.7).2.3. Normal human serum (NHS)
NHS used in the assays on the complement system was obtained
from blood of healthy volunteers of both sexes, aged 20 to 40 years,
collected in the absence of anticoagulants. The blood was allowed to
clot at room temperature for 1 h, and the serum was separated from
the clot by centrifugation at 500 ×g for 10 minutes at 4 °C. Then, serum
was pooled, aliquoted and frozen at −80 °C until the experiments. All
procedures involving humans were approved by the Research Ethics
Committee of FCFRP-USP (CEP/FCFRP nº. 123/2011).
2.4. Effects on the complement system
The effects of B. pirajai serine proteases on the human comple-
ment system were observed using in vitro assays to assess the hemo-
lytic activity promoted by NHS, source of complement components,
preincubated for 1 h at 37 °C with different concentrations of the
enzymes. Prior to these assays, the serine proteases were investigated
for their ability to induce direct hemolysis by incubation with rabbit
or sheep erythrocytes in the absence of NHS.
2.4.1. Preparation of erythrocyte suspensions
For CP/LP, blood from three sheep was collected by venipuncture
of the jugular vein into plastic tubes containing the same volume of
Alsever sterile solution (2.05% glucose, 0.8% sodium citrate and
0.42% NaCl). Aliquots of blood were centrifuged at 500 ×g for 10 mi-
nutes and the pellet of red cells was then washed with triethanolamine
buffer pH 7.4 containing 1.4 × 10−4 M CaCl2, 5 × 10−4 M MgSO4 and
0.1% gelatin (TEA–Ca2+–Mg2+ buffer), preparing a 5% erythrocyte
suspension with approximately 1.2 × 109 cells/mL [24]. Then, this
suspension was sensitized with rabbit anti-sheep erythrocyte antibod-
ies (hemolysin), kept at 4 °C for 15 minutes and the absorbance at
700 nm was adjusted to 0.7–0.8 in a spectrophotometer (Beckman
Coulter, model DU-70).
For AP, blood from two rabbits was collected by puncture of the
central ear artery into plastic tubes containing the same volume of
Alsever sterile solution. Then, blood was incubated with the same vol-
ume of a TEA–EDTA chelating solution for 15 minutes at 37 °C. After
centrifugation, the red cells were washed with TEA–Mg2+ buffer,
suspended in Alsever’s solution and stored at 4 °C. For the hemolytic
assays, aliquots of this suspension were washed with triethanolamine
buffer pH 7.4 containing 8 × 10−3 M EGTA, 2 × 10−3 M MgSO4 and
0.1% gelatin (TEA–EGTA–Mg2+ buffer), preparing a 5% erythrocyte
suspension and adjusting the absorbance at 700 nm to 0.7–0.8 in a
spectrophotometer.
2.4.2. Hemolytic assays by kinetic method
Assays for CP/LP and AP were performed by a kinetic method, using
different concentrations of the serine proteases (25–200 μg/mL) incu-
batedwith NHS at 37 °C for 1 h in 96-well microplates. After the incuba-
tion, residual complement activity was measured by adding sensitized
sheep erythrocytes (CP/LP) or rabbit erythrocytes (AP) to each well.
The reaction mixtures were homogenized and the absorbance at
700 nmwas assayed for 15 minutes in amicroplate reader (SpectraMax
Plus, Molecular Devices). NHS diluted with TEA–Ca2+–Mg2+ buffer or
TEA–EGTA–Mg2+ buffer in the absence of the enzymes were employed
as 100% lysis controls for CP/LP and AP, respectively. This methodology
does not allow distinguishing between CP and LP, since both pathways
share C2, C4 and C3 convertase.
The hemolytic activity was expressed by t½, which corresponds to
the time (in seconds) required to occur lysis of 50% of the erythrocytes
present in the reaction mixture, and is directly proportional to the per-
centage of inhibition of the complement system hemolytic activity [25].
Values of t½were calculated from the absorbance results, corresponding
to the time required for the absorbance of the reaction mixture to be
reduced by half. The percentage of inhibition of the hemolytic activity
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2.5. Proinﬂammatory effects
2.5.1. Edema-inducing activity
The edema induced by the enzymes was evaluated in male Wistar
rats, with each animal group (n = 4) receiving different doses of the
serine proteases (10, 25 and 50 μg) diluted in 50 μL of sterile phos-
phate buffered saline (PBS) by intraplantar injection into the left
hind paw of animals. The right hind paw received only PBS as a nega-
tive control. The volumes of both paws were measured using a
plethysmometer (Ugo Basile, Comerio, Italy, model 7140) before and
at different time intervals (1, 2, 3, 4, 5 and 6 h) after injection of PBS
or enzymes, according to Van Arman and colleagues [26]. Results were
calculated as the difference between the values obtained for both paws
and expressed as percentages of increase in paw volume in relation to
the initial measurements (before injection).
2.5.2. Hyperalgesia
The same animals used in the edema-inducing activity were assessed
for the hyperalgesia promoted by B. pirajai serine proteases. The pain
thresholdwasmeasuredwith a pressure apparatus (Ugo-Basile, Comerio,
Italy) before and at different times (1, 2, 3, 4, 5 and 6 h) after injection of
PBS or enzymes, according to Randall and Selitto [27]. The weight
(in grams) required to cause a nociceptive response (paw bending)
was determined as the nociceptive threshold. A cutoff value of 300 g
was used to avoid damage to the paws. Results were calculated as the
difference between the values obtained for both paws and expressed
as percentages of decrease in nociceptive threshold in relation to the
initial measurements (before injection).
2.5.3. Peritoneal inﬂammatory exudate analysis
Balb/C mice (4 animals/group) were injected intraperitoneally
with 500 μL of PBS (negative control) or solutions of B. pirajai crude
venom (25 μg in 500 μL of PBS) and of the isolated serine proteases
(25, 50 and 100 μg in 500 μL of PBS). After 6 and 24 h, the animals
were euthanized by instillation of CO2 and their peritoneal cavities
were washed with 5 mL of cold PBS, draining the exudate aseptically
with a syringe. The total leukocyte count was performed in a Neubauer
chamber, analyzing each exudate sample diluted in Turk's solution
(1:20). The differential leukocyte count in polymorphonuclear or
mononuclear cells was done by concentrating the different exudate
samples on microscope slides using Cytospin (Shandon Souther Prod-
ucts Ltd., Manchester, UK), followed by staining with Romanowsky
stain and examination under an optical microscope (Bioval, São Paulo,
Brazil) at magniﬁcation of 400×. Three hundred cells were counted
per slide and the results were expressed as percentages of each cell
type observed.
2.6. Endotoxin quantiﬁcation
To ensure that the results obtained on the complement systemand on
inﬂammation were not related to the presence of bacterial endotoxins in
the serine protease samples, the amount of LPS (lipopolysaccharides)
was tested using the limulus amebocyte lysate (LAL) QCL-1000® kit
(Lonza, São Paulo, Brazil), according to the manufacturer's instructions.
Samples of the serine proteases were evaluated after preincubation at
37 °C with excess of the inhibitor benzamidine (20 mM) for 1 h to
ensure that their enzymatic activity would not inﬂuence the test. Theendotoxin quantiﬁcation was done based on a standard curve with
various concentrations of Escherichia coli endotoxin (0.1 to 1.0 EU/mL).
2.7. Statistical analysis
The experiments were performed in triplicate or quadruplicate and
the results were expressed asmean values ± standard deviations (SD).
The statistical signiﬁcance of results was calculated by the program
GraphPad Prism 5, using analysis of variance (ANOVA) followed by
Tukey test and considering p values b0.05 as signiﬁcant.
3. Results
The dosage of bacterial endotoxins in the serine protease samples
showed values below 0.1 EU/mL (results not shown), excluding the
possibility that the observed effects on the complement system and
inﬂammatory processes could be related to the presence of LPS. In
addition, B. pirajai serine proteases were not able to promote direct
hemolysis of rabbit or sheep erythrocytes (results not shown), allowing
the use of a kinetic hemolytic method for the determination of their
effects on the human complement system.
After incubation of the enzymeswith NHS for 1 h at 37 °C, the CP/LP
hemolytic activity proved to be signiﬁcantly reduced compared to the
control without the serine proteases, as shown by the values of t½
(Fig. 1). Both BpirSP27 (Fig. 1A) and BpirSP41 (Fig. 1B) induced a signif-
icant increase of t½ (p b 0.05) at all the tested concentrations, indicat-
ing modulation of CP/LP by both enzymes. Regarding the inhibition of
the AP hemolytic activity, it was shown that B. pirajai serine proteases
promoted signiﬁcant increases of t½atmost of the tested concentrations
(Fig. 2). The analysis of the percentage of inhibition of the hemolytic
activity promoted by the complement pathways clearly showed that
BpirSP41 promoted greater modulation of CP/LP compared to BpirSP27,
with inhibition values close to 40% and 20%, respectively, at the concen-
tration of 200 μg/mL (Fig. 3A), while the modulation of AP was less pro-
nounced, with both enzymes presentingmaximal inhibition around 20%
at the highest analyzed concentrations (Fig. 3B).
The results related to inﬂammation suggested that B. pirajai serine
proteases possess a minor role in the induction of edema (Fig. 4) and
pain (Fig. 5) in rats. Regarding the edema-inducing activity, BpirSP27
apparently showed a dose-dependent behavior, although the increase
in the volume of paw injected with this enzyme did not exceed ~14% at
the highest tested dose (50 μg) (Fig. 4A). Additionally, all doses showed
similar edema proﬁles, with a signiﬁcant increase after 1 h of the en-
zyme injection and another peak response after 4 h, especially at the
dose of 50 μg (Fig. 4A). In the case of BpirSP41, the edema proﬁles pro-
moted by the tested doses were more variable (Fig. 4B), with doses of
25 and 50 μg showing very similar responses, with a signiﬁcant peak re-
sponse (p b 0.05) after 4 h of the enzyme injection, while the dose of
10 μg did not show pronounced peak responses. Similarly to BpirSP27,
BpirSP41 was unable to induce edema superior to ~12% at the tested
doses (Fig. 4B). Moreover, the decrease in the nociceptive threshold in-
duced by both B. pirajai serine proteases was very modest, with few
values signiﬁcantly different from the initial thresholds (p b 0.05) and
not exceeding 15% (Fig. 5). Furthermore, the nociceptive proﬁles in-
duced by different doses of both enzymes varied greatly, with no clear
dose-dependent effect observed. At the dose of 50 μg, BpirSP27 induced
a pain peak response after 3 h of injection (Fig. 5A), while BpirSP41 in-
duced a rather different proﬁle, with a sharp peak response after 1 h of
injection and another one after 4 h (Fig. 5B).
The evaluation of the peritoneal inﬂammatory exudates induced
in mice after 6 or 24 h of administration of different doses of B. pirajai
serine proteases (Fig. 6) showed that none of the enzymes promoted
signiﬁcant increases (p b 0.05) in the number of leukocytes present in
the peritoneal cavity at all tested doses when compared to the negative
control (PBS). In contrast, B. pirajai crude venom (25 μg) displayed a
signiﬁcant increase (p b 0.05) in the total number of leukocytes both
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Fig. 1. Effects of the serine proteases BpirSP27 (A) and BpirSP41 (B) on the hemolytic activity of the classical/lectin pathways (CP/LP) of the human complement system. t½ cor-
responds to the time (in seconds) required for the occurrence of 50% hemolysis by the complement system. One hundred percent lysis control (C) represents the hemolytic activity
of NHS in the absence of the enzymes. Results are expressed as mean values ± SD (n = 3). (*) Values signiﬁcantly different from the control (p b 0.05).
767D.L. Menaldo et al. / International Immunopharmacology 15 (2013) 764–771after 6 and 24 h of administration (Fig. 6). In addition, differentiation of
the leukocytes present in these exudates in polymorphonuclear cells
(mainly neutrophils) and mononuclear cells (lymphocytes and mono-
cytes) (Fig. 7) showed that, after 6 h of administration, both serine
proteases and B. pirajai crude venom promoted signiﬁcant increases
(p b 0.05) of neutrophils when compared to the negative control of
PBS (Fig. 7A). After 24 h, the number of neutrophils remained signif-
icantly higher for B. pirajai crude venom and for some doses of the
isolated enzymes in comparison to that of the negative control (Fig. 7B),
but the values were less prominent than those observed after 6 h of
injection.0
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to form complexes capable of activating and amplifying the comple-
ment cascade [28]. Regarding Bothrops venoms, Pidde-Queiroz and
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of sensitizing antibody, and the activation was shown to be at least
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components (C3 and C4) was evaluated using speciﬁc inhibitors of
metalloproteases and serine proteases (1,10-phenanthroline and
phenylmethylsulfonyl ﬂuoride — PMSF, respectively), and the results
indicated that these should be themain venomconstituents responsible
for the effects observed on the human complement system [17].
Some isolated snake venom toxins were already described with
action on the complement system. The cobra venom factor (CVF) from
Naja naja kaouthia venom, for example, directly promoted cleavage of
complement proteins, such as C2, C3 and C4, and stabilization of the
C3 convertase of AP, generating ampliﬁcation of the activation cascade
and formation of the anaphylatoxins C3a and C5a, as well as other acti-
vation fragments as C3b and C4b [29]. A protease from Vipera lebetina0
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(p b 0.05).venom decreased the hemolytic activity related to CP and AP due to
the proteolytic cleavage of the α chain of C3 and C4 components [30].
The metalloprotease atrase B isolated from Naja atra venom inhibited
the activation of AP and CP of the complement in a dose-time-
dependent manner, cleaving the components C6, C7, C8 and fac-
tor B [21]. Regarding the class of serine proteases, ﬂavoxobin
from T. ﬂavoviridis venom was able to activate AP, acting as a C3
convertase that independently and speciﬁcally cleaves human C3
at the Arg726–Ser727 site to form C3a and C3b, initiating the
complement cascade [22].
In the case of B. pirajai serine proteases, the increase of t½observed
after incubation of NHSwith the enzymes indicates their action on the
complement, although it is not possible, only by themethodology used0
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769D.L. Menaldo et al. / International Immunopharmacology 15 (2013) 764–771in this study, to conclude if the effects are due to activation and/or inac-
tivation of components or inhibition of activation pathways and/or of
regulatory proteins of the system. Nevertheless, considering that
BpirSP27 and BpirSP41 are thrombin-like enzymes, it is possible that
those SVSPs act directly on different complement components as previ-
ously stated for thrombin, which dose- and time-dependently generated
C5a in the absence of C3 and C3a in the presence of C3 [15].
B. pirajai serine proteases presented mild effects on inﬂammatory
processes such as the induction of edema and pain, suggesting that these
enzymes should possess a minor role in the inﬂammation promoted by0
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theperitoneal cavity ofmice after injection of PBS (NC, negative control), B. pirajai crude venom
PBS) was counted in a Neubauer chamber. Results are expressed as mean values ± SD (n = 4B. pirajai venom, similarly to that reported for Bothrops jararaca venom
[31]. In fact, the thrombin-like enzyme TLBm isolated from the venom
of Bothrops marajoensis showed similar edema-inducing results to
BpirSP27 and BpirSP41, promoting no signiﬁcant increases in the paw
volume of mice injected with doses up to 20 μg and not inducing the in-
ﬂammatory inﬁltrate characteristic of Bothrops envenomations [32].
Several studies show the action of Bothrops venoms in the induc-
tion of edema and pain in rats and mice, with very low doses inducing
exacerbated effects, often accompanied by hemorrhage [33–38]. This
suggests the participation of metalloproteases in these processes, whichTo
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Fig. 7. Differential leukocyte count of the peritoneal inﬂammatory exudates after 6 h (A) and 24 h (B) of administration of B. pirajai serine proteases. The leukocytes present in the
peritoneal cavity of mice after injection of PBS (NC, negative control), B. pirajai crude venom (SV, 25 μg in 500 μL of PBS) or enzymes (BpirSP27/BpirSP41, 25, 50 and 100 μg in
500 μL of PBS) were differentiated in neutrophils and mononuclear cells by analysis under an optical microscope at magniﬁcation of 400×. Results are expressed as mean percentages
of each cell type ± SD (n = 4). (*) Values for both cell types signiﬁcantly different from NC (p b 0.05).
770 D.L. Menaldo et al. / International Immunopharmacology 15 (2013) 764–771promote these effects due to the hydrolysis of vessel proteins, inducing
an inﬂammatory process accompanied by neutrophil migration and re-
lease of inﬂammatory mediators, with increased vascular diameter and
plasma extravasation [1].
The edema and pain induced by Bothrops venoms are usually re-
lated to the formation of arachidonic acid metabolites such as prosta-
glandins and leukotrienes, formed by the action of cyclooxygenases
and lipoxygenases, respectively. Other mediators commonly associated
with these effects are histamine, serotonin, bradykinin, nitric oxide and
platelet activating factor (PAF) [1,38–40]. As B. pirajai serine proteases
did not present substantial edema-inducing and nociceptive effects, it
was not possible to assess which are the mediators involved in the
low levels of edema and pain induced by these enzymes.
Corroborating the proinﬂammatory effects described so far, the
assessment of the inﬂammatory exudates induced by B. pirajai serine
proteases showed that these enzymes promoted no signiﬁcant increases
(p b 0.05) in the total number of leukocytes present in the peritoneal
cavity of mice after 6 and 24 h of administration, differently from that
observed for B. pirajai crude venom. Although the enzymes BpirSP27
and BpirSP41 did not induce a signiﬁcant quantitative increase, a promi-
nent inﬁltration of neutrophils was observed in the exudates after 6 h of
administration, indicating that these enzymes should contribute, even if
to a lesser extent, to the acute inﬂammatory response promoted by
B. pirajai venom. After 24 h of administration, an increased neutrophil
count remained at some doses, but themajority of leukocytes present in
the exudates were mononuclear cells.
Leukocytes are key elements in the inﬂammatory responses due to
their phagocytic and secretory activities, migrating to the affected
area in response to various inﬂammatory stimuli. In the acute inﬂam-
matory response, neutrophils rapidly migrate to the injured site, being
the main responsible for the initial phagocytosis of infectious agents
and the release of cytokines [1,41]. Several Bothrops venoms have
been described as able to induce different levels of leukocyte migration
up to 72 h after their administration [31,42–44], and though some stud-
ies attributed this ability mainly to metalloproteases [31,45], our results
indicated that SVSPs could also be involved in this process.
It is possible that the edema, pain and the increase of neutrophils
after injection of B. pirajai serine proteases is related to the formationof the anaphylatoxins C3a, C4a and C5a due to the action of these SVSPs
on the respective components of the complement system, though other
studies are necessary to conﬁrm or refute this hypothesis. As amatter of
fact, C5a exhibits a broad spectrumof inﬂammatory activities, including
neutrophil chemoattraction and hypernociception by a mechanism
independent of cytokine release, but dependent on the presence of neu-
trophils [46].
Comparing the proinﬂammatory activities of BpirSP27 and BpirSP41
with those of a P-I class metalloprotease (BpirMP) (unpublished results)
and a Lys49 phospholipase A2 (piratoxin-I) [47] also from B. pirajai
venom, it is possible to suggest that the induction of pain and edema is
not directly related to these serine proteases. Some studies showed that
this class of enzymes could be indirectly involved in the local inﬂamma-
tion caused by snake venoms by promoting blood pressure disturbances
[31] or releasing endogenousmetalloproteases [48]. Also, considering the
correlation between coagulation and complement components, and their
subsequent effects on inﬂammation [12,13], it is possible that the effects
reported for B. pirajai serine proteases on the inﬂammatory processes in
vivo are somehow related to their actions on the hemostatic system.
5. Conclusions
The results regarding the complement system suggested that B. pirajai
serine proteases were able to induce modulation of CP/LP and AP at
different levels, with BpirSP41 causing greater inhibition of the CP/LP
hemolytic activity compared to BpirSP27, and both presenting similar
inhibitory effects on the hemolytic activity of AP. Further studies using
isolated complement components such as C2, C3, C4 and C5, as well as
the investigation of the generation of cleavage fragments, as C3a and
C5a, should be performed in order to elucidate themechanisms of action
of these enzymes on the human complement system.
In relation to the proinﬂammatory effects of the serine proteases,
both presented mild effects on processes such as the induction of
edema and pain, promoting a pronounced neutrophil recruitment with-
out inducing signiﬁcant increases in the total number of leukocytes in the
peritoneal inﬂammatory exudate after 6 and 24 h of their administra-
tion. These results suggest that these enzymes should present a minor
role in the inﬂammation caused by the venom of B. pirajai.
771D.L. Menaldo et al. / International Immunopharmacology 15 (2013) 764–771Considering that the serine proteases BpirSP27 and BpirSP41
presented signiﬁcant differences in their amino acid sequences and
functional activities [23], the fact that their effects on the complement
system and inﬂammation were mostly similar and mild indicates that
those immunological responses do not seem to be key targets of this
class of snake venom enzymes.
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